Intrexon reported $0 in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 3.06M 107K
Anika Therapeutics ANIK:US USD 146K 0
Arrowhead Research ARWR:US USD 199K 1000
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 829K 94K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Heron Therapeutics HRTX:US USD 1.19M 163K
Immunogen IMGN:US USD 2.26M 52K
Macrogenics MGNX:US USD 617K 2K
Mannkind MNKD:US USD 2.64M 6K
Novartis NOVN:VX USD 890M 0
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Rigel Pharmaceuticals RIGL:US USD 174K 1000
Roche Holding ROG:VX 107M 0
Sangamo Biosciences SGMO:US USD 1.67M 49K
Veracyte VCYT:US USD 72K 0
Xencor XNCR:US USD 601K 3K
Ziopharm Oncology ZIOP:US USD 240K 24K